Meningiomas and haemangiopericytoma (HPC)

Abstract

Meningiomas are the most common primary brain tumours and account for 36.7% of all primary intracranial neoplasms. Taking into account population increases in the United States, 150 000 people currently may have a diagnosis of meningioma, with an incidence rate of 3–3.5 per 100 000. General management principles of meningiomas and location-specific treatment considerations are discussed. Surgery is the primary and main treatment for most meningiomas with radiotherapy used in biologically and clinically aggressive meningiomas. Not all meningiomas require urgent treatment and many meningiomas are be best managed with radiological follow-up. The most recent biological and genetics literature is reviewed.